Marie F. Du Pre

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Correction: B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2.

Correction: B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2.

Journal: The Journal of experimental medicine
Published: February 12, 2026

Peyer's Patch B Cells Sample Transglutaminase-Gluten Complexes and Drive Celiac Disease Autoimmunity.

Peyer's Patch B Cells Sample Transglutaminase-Gluten Complexes and Drive Celiac Disease Autoimmunity.

Journal: Gastroenterology
Published: April 29, 2025

IFN-γ is a direct driver of crypt hyperplasia in celiac disease.

IFN-γ is a direct driver of crypt hyperplasia in celiac disease.

Journal: The Journal of clinical investigation
Published: April 22, 2025

T cell receptor precision editing of regulatory T cells for celiac disease.

T cell receptor precision editing of regulatory T cells for celiac disease.

Journal: Science translational medicine
Published: March 19, 2025

A Mouse Model for Generation of Gut Lamina Propria Plasma Cells Specific for a Deamidated Gluten Peptide.

A Mouse Model for Generation of Gut Lamina Propria Plasma Cells Specific for a Deamidated Gluten Peptide.

Journal: European journal of immunology
Published: November 11, 2024

Coeliac disease: the paradox of diagnosing a food hypersensitivity disorder with autoantibodies.

Coeliac disease: the paradox of diagnosing a food hypersensitivity disorder with autoantibodies.

Journal: Gut
Published: December 11, 2023

Enterocyte-Derived and Catalytically Active Transglutaminase 2 in the Gut Lumen of Mice: Implications for Celiac Disease.

Enterocyte-Derived and Catalytically Active Transglutaminase 2 in the Gut Lumen of Mice: Implications for Celiac Disease.

Journal: Gastroenterology
Published: December 05, 2023

Transglutaminase 2 affinity and enzyme-substrate intermediate stability as determining factors for T-cell responses to gluten peptides in celiac disease.

Transglutaminase 2 affinity and enzyme-substrate intermediate stability as determining factors for T-cell responses to gluten peptides in celiac disease.

Journal: European journal of immunology
Published: February 15, 2022

Injection of prototypic celiac anti-transglutaminase 2 antibodies in mice does not cause enteropathy.

Injection of prototypic celiac anti-transglutaminase 2 antibodies in mice does not cause enteropathy.

Journal: PloS one
Published: December 12, 2021

TG2-gluten complexes as antigens for gluten-specific and transglutaminase-2 specific B cells in celiac disease.

TG2-gluten complexes as antigens for gluten-specific and transglutaminase-2 specific B cells in celiac disease.

Journal: PloS one
Published: January 14, 2021

A high-affinity human TCR-like antibody detects celiac disease gluten peptide-MHC complexes and inhibits T cell activation.

A high-affinity human TCR-like antibody detects celiac disease gluten peptide-MHC complexes and inhibits T cell activation.

Journal: Science immunology
Published: January 11, 2021

Generation of an HLA-DQ2.5 Knock-In Mouse.

Generation of an HLA-DQ2.5 Knock-In Mouse.

Journal: ImmunoHorizons
Published: December 01, 2020
Showing 1-12 of 25

Last Updated: 09/26/2026